RecruitingNot ApplicableNCT03987334

Virtual Reality Rehabilitation in Neck Pain Subjects

Effects of Virtual Reality Motor Control Rehabilitation in Neck Pain Subjects


Sponsor

IRCCS San Raffaele

Enrollment

72 participants

Start Date

May 9, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

VR-NECKPAIN is a two-arm, monocentric, single-blind, randomized controlled trial in Neck Pain patients. The entire treatment consist in 12 sessions, each during 45 minutes, twice a week for 6 consecutive weeks. Subjects will be evaluated ad baseline (T0) and after six weeks of rehabilitation (T1). There will also be a 3 months Follow-Up assessment (T2). The total duration of study participation for each subject will be approximately 19 weeks, including evaluation at T0, treatment and evaluation at T1 and T2. Individuals in the experimental group (VRT) will undergo a virtual reality-based sensorimotor rehabilitation. Control group (CT) subjects will undergo the same rehabilitation of VR subjects, in terms of intensity, time and type, but with the virtual reality turned off.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria3

  • Adult individuals (18-70 years old);
  • Neck Pain (Chronic Neck Pain or Whiplash);
  • Normal vision or corrected vision.

Exclusion Criteria7

  • Informed Consent negation;
  • System infection or metabolic/neurological/muscular degenerative disorder;
  • Cervical spinal pathology, fracture or surgery;
  • Radiculopathy;
  • Vestibular impairments;
  • Epilepsy;
  • Pregnancy.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVirtual Reality Treatment

Experimental Group (VRT) subjects will undergo Virtual Reality Motor Control exercises based on augmented feedback of their performance.

OTHERControl Group

Control Group (CT) subjects will undergo the same treatment of VRT subjects in terms of intensity, time and type, but with the VR turned off.


Locations(1)

IRCSS Ospedale San Raffaele

Milan, MI, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03987334


Related Trials